Shire announces findings from Phase 3 study data with Vyvanse
Links shared publicly online about this topic.
- 1,606total visits
Shire announces findings from Phase 3 study data with Vyvanse
View full resource at news-medical.net
Tags: Stroke, ADHD Medication, Emotional Health, Thrombotic Event, Disease and Condition, Phase 3 Clinical Trial, Vyvanse, Shire
Most Recently Shared on November 13, 2009 at 10:12 am By:
Stroke News: Shire announces findings from Phase 3 study data with Vyvanse: Shire plc, the global s.. http://twurl.nl/hs1qon
Shire Reports Analysis Examining Emotional Lability In Children With ADHD Taking Vyvanse | Psydir News
news.psydir.com — “Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced findings from a post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse. In this study, Vyvanse demonstrated significant improvement in Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms as measured by the ADHD Rating Scale IV (ADHD-RS IV) and Connors' Parent Rating Sc...” View full resource at news.psydir.com
Most Recently Shared on November 14, 2009 at 2:28 pm By:
Shire Reports Analysis Examining Emotional Lability In Children With ADHD Taking Vyvanse http://ow.ly/161DTb
Shire Reports Analysis Examining Emotional Lability In Children With ADHD Taking Vyvanse
medicalnewstoday.com — “Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced findings from a post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse&r” View full resource at medicalnewstoday.com
Most Recently Shared on November 14, 2009 at 12:57 pm By:
MNT Psychology News Health News
Shire Reports Analysis Examining Emotional Lability In Children With ADHD Taking Vyvanse: Shire plc (LSE: SHP, .. http://bit.ly/L7ol7
Shire Reports Analysis Examining Emotional Lability In Children With ADHD Taking Vyvanse
medicalnewstoday.com — “Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced findings from a post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse&r” View full resource at medicalnewstoday.com
Most Recently Shared on November 14, 2009 at 12:32 pm By:
MNT Pediatrics News Health News and Pediatrics
Shire Reports Analysis Examining Emotional Lability In Children With ADHD Taking Vyvanse: Shire plc (LSE: SHP, .. http://bit.ly/34ZvnZ
Shire Reports Findings From An Analysis Examining Emotional Lability In Children With ADHD Taking Vyvanse(R) (lisdexamfetamine Dimesylate) Capsules
medicalnewstoday.com — “Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced findings from a post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse&r” View full resource at medicalnewstoday.com
Most Recently Shared on November 13, 2009 at 1:10 pm By:
MNT Clinical Trials Health News
Shire Reports Findings From An Analysis Examining Emotional Lability In Children With ADHD Taking Vyvanse(R) (l.. http://bit.ly/36XeTm
Advertisement
